Vaccine Development

Vaccine development has generated some huge successes in recent years, both in generating new preventative approaches for infectious disease and virus associated cancers.

However, there are still many diseases for which new and better vaccines are required, and the range of adjuvants available for inclusion in new vaccines needs to be expanded. KWS BioTest can offer different testing platforms to determine the immunogenicity of novel vaccines in human as well as model systems, and has infection models which can be used to carry out challenge experiments in many diseases.

A selection of the main vaccine models offered includes:

• Human in vitro immunogenicity 
• Immunogenicity and antigenicity
• Influenza models
• Herpes simplex virus models
• Leishmania models
• Renal carcinoma models
• Epstein-Barr virus-associated tumours

KWS has a range of TCR transgenics and other models in which it can monitor the nature and extent of immune responses to novel vaccine candidates.